Fresenius Medical Care AG (FMS) Cash & Current Investments (2009 - 2025)

Fresenius Medical Care AG (FMS) has 17 years of Cash & Current Investments data on file, last reported at $2.4 billion in Q4 2025.

• In Q4 2025, Cash & Current Investments rose 38.08% year-over-year to $2.4 billion; the TTM figure through Dec 2025 stood at $2.4 billion (up 38.08% YoY), while the FY2025 annual figure was $2.4 billion, up 38.08% from the prior year.
• Cash & Current Investments grew to $2.4 billion in Q4 2025, from $2.1 billion in the prior quarter.
• Across five years, Cash & Current Investments topped out at $2.5 billion in Q2 2025 and bottomed at $1.3 billion in Q3 2021.
• A 5-year average of $1.7 billion and a median of $1.6 billion in 2022 frame the typical range for Cash & Current Investments.
• Annual changes were most pronounced in 2023 — Cash & Current Investments dropped 17.78% — and 2024, when it surged 39.64%.
• Year by year, Cash & Current Investments stood at $1.7 billion in 2021, then decreased by 8.62% to $1.6 billion in 2022, then rose by 15.84% to $1.8 billion in 2023, then dropped by 4.11% to $1.7 billion in 2024, then surged by 38.08% to $2.4 billion in 2025.
• The last three Cash & Current Investments figures came in at $2.4 billion (Q4 2025), $2.1 billion (Q3 2025), and $2.5 billion (Q2 2025), per Business Quant data.

Peer Comparison